Log In
Print this Print this

HDAC6 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Kancera AB
DescriptionHistone deacetylase 6 (HDAC6) inhibitor
Molecular Target Histone deacetylase 6 (HDAC6)
Mechanism of ActionHistone deacetylase 6 (HDAC6) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today